Kohei Tsuji

1.1k total citations
57 papers, 776 citations indexed

About

Kohei Tsuji is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Kohei Tsuji has authored 57 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 14 papers in Infectious Diseases and 14 papers in Organic Chemistry. Recurrent topics in Kohei Tsuji's work include Chemical Synthesis and Analysis (14 papers), HIV Research and Treatment (13 papers) and HIV/AIDS drug development and treatment (11 papers). Kohei Tsuji is often cited by papers focused on Chemical Synthesis and Analysis (14 papers), HIV Research and Treatment (13 papers) and HIV/AIDS drug development and treatment (11 papers). Kohei Tsuji collaborates with scholars based in Japan, United States and Germany. Kohei Tsuji's co-authors include Akira Otaka, Akira Shigenaga, Kohei Sato, Terrence R. Burke, Kosuke Tanegashima, Takahiko Hara, Ken Sakamoto, Shugo Tsuda, Osamu Tomita and Ryu Abe and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Kohei Tsuji

52 papers receiving 767 citations

Peers

Kohei Tsuji
Jan D. Kahmann United Kingdom
Jiqing Ye United States
Terence K. Brunck United States
Zoltán Székely United States
Origène Nyanguile United States
Kohei Tsuji
Citations per year, relative to Kohei Tsuji Kohei Tsuji (= 1×) peers Alessandro Canella

Countries citing papers authored by Kohei Tsuji

Since Specialization
Citations

This map shows the geographic impact of Kohei Tsuji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kohei Tsuji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kohei Tsuji more than expected).

Fields of papers citing papers by Kohei Tsuji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kohei Tsuji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kohei Tsuji. The network helps show where Kohei Tsuji may publish in the future.

Co-authorship network of co-authors of Kohei Tsuji

This figure shows the co-authorship network connecting the top 25 collaborators of Kohei Tsuji. A scholar is included among the top collaborators of Kohei Tsuji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kohei Tsuji. Kohei Tsuji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuji, Kohei, et al.. (2025). Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry Inhibitors. Journal of Medicinal Chemistry. 68(24). 25899–25911.
2.
Kobayakawa, Takuya, et al.. (2025). Diastereoselective synthesis of ( Z )-fluoroalkene dipeptide isosteres utilizing chiral auxiliaries. Organic & Biomolecular Chemistry. 23(18). 4333–4336.
3.
Kobayakawa, Takuya, et al.. (2024). Naphthalen-1-ylethanamine–containing small molecule inhibitors of the papain-like protease of SARS-CoV-2. European Journal of Medicinal Chemistry. 280. 116963–116963. 3 indexed citations
4.
Tsuji, Kohei, Hirokazu Tamamura, & Terrence R. Burke. (2024). Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein. Bioorganic & Medicinal Chemistry. 119. 118055–118055. 1 indexed citations
5.
Tsuji, Kohei, Takahiro Ishii, Takuya Kobayakawa, et al.. (2023). Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2. RSC Advances. 13(13). 8779–8793. 4 indexed citations
6.
Kobayakawa, Takuya, Masaru Yokoyama, Kohei Tsuji, et al.. (2023). Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical and Pharmaceutical Bulletin. 72(1). 41–47. 2 indexed citations
7.
Ishii, Takahiro, Takuya Kobayakawa, Kouki Matsuda, et al.. (2023). Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. European Journal of Medicinal Chemistry. 256. 115449–115449. 8 indexed citations
8.
Kobayakawa, Takuya, Masaru Yokoyama, Kohei Tsuji, et al.. (2023). Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins. RSC Advances. 13(3). 2156–2167. 5 indexed citations
9.
Tsuji, Kohei, Takuya Kobayakawa, Takahiro Ishii, et al.. (2023). Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical and Pharmaceutical Bulletin. 71(12). 879–886. 3 indexed citations
10.
Tsuji, Kohei, David Hymel, Buyong Ma, et al.. (2022). Development of ultra-high affinity bivalent ligands targeting the polo-like kinase 1. RSC Chemical Biology. 3(9). 1111–1120. 8 indexed citations
12.
Koshikawa, Nobuko, Kohei Tsuji, Takayoshi Watanabe, et al.. (2021). A linear five-ring pyrrole-imidazole polyamide-triphenylphosphonium conjugate targeting a mitochondrial DNA mutation efficiently induces apoptosis of HeLa cybrid cells carrying the mutation. Biochemical and Biophysical Research Communications. 576. 93–99. 7 indexed citations
13.
Kobayakawa, Takuya, Kohei Tsuji, Masayuki Fujino, et al.. (2020). Bivalent HIV-1 fusion inhibitors based on peptidomimetics. Bioorganic & Medicinal Chemistry. 28(24). 115812–115812. 2 indexed citations
14.
Tsuji, Kohei, Takuya Kobayakawa, Masayuki Fujino, et al.. (2020). Exploratory studies on CA-15L, an anti-HIV active HIV-1 capsid fragment. Bioorganic & Medicinal Chemistry. 28(11). 115488–115488. 8 indexed citations
15.
Tsuji, Kohei, et al.. (2019). Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody–Drug Conjugates. Bioconjugate Chemistry. 30(11). 2889–2896. 31 indexed citations
16.
Tsuji, Kohei, Kosuke Tanegashima, Kohei Sato, et al.. (2015). Efficient one-pot synthesis of CXCL14 and its derivative using an N-sulfanylethylanilide peptide as a peptide thioester equivalent and their biological evaluation. Bioorganic & Medicinal Chemistry. 23(17). 5909–5914. 12 indexed citations
17.
Tsuji, Kohei, Teruhiko Baba, Akira Shigenaga, et al.. (2015). Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes. Journal of Biological Chemistry. 290(34). 20947–20959. 12 indexed citations
18.
Tsuji, Kohei, Akira Shigenaga, Kohjiro Nagao, et al.. (2013). The extreme N‐terminal region of human apolipoprotein A‐I has a strong propensity to form amyloid fibrils. FEBS Letters. 588(3). 389–394. 22 indexed citations
19.
Tanegashima, Kosuke, Kohei Tsuji, Kenji Suzuki, et al.. (2013). Dimeric peptides of the C‐terminal region of CXCL14 function as CXCL12 inhibitors. FEBS Letters. 587(23). 3770–3775. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026